M.G. Scordo
- Pharmacology top 0.2%
- Psychiatry and Mental health top 5%
- Oncology
- Endocrinology, Diabetes and Metabolism top 5%
- Pharmacology top 5%
- Co-authors
- Edoardo SpinaAngela AvenosoAldo MadiaM. AncioneEmilio PeruccaMarja‐Liisa DahlMats HidestrandNorio Yasui‐Furukori
- Topics
- Pharmacogenetics and Drug Metabolism (10 papers)Schizophrenia research and treatment (6 papers)Diet and metabolism studies (4 papers)
- Partner nations
- SwedenItalyUnited States
In The Last Decade
M.G. Scordo
16 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 79
- Pharmacology 733
- Psychiatry and Mental health 319
- Oncology 220
- Endocrinology, Diabetes and Metabolism 199
- Pharmacology 182
Countries citing papers authored by M.G. Scordo
This map shows the geographic impact of M.G. Scordo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.G. Scordo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.G. Scordo more than expected).
Fields of papers citing papers by M.G. Scordo
This network shows the impact of papers produced by M.G. Scordo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.G. Scordo. The network helps show where M.G. Scordo may publish in the future.
Co-authorship network of co-authors of M.G. Scordo
This figure shows the co-authorship network connecting the top 25 collaborators of M.G. Scordo. A scholar is included among the top collaborators of M.G. Scordo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.G. Scordo. M.G. Scordo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 53 | |
| 3 | 116 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 14 | |
| 7 | 12 | |
| 8 | 1 | |
| 9 | 181 | |
| 10 | 44 | |
| 11 | 264 | |
| 12 | Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes. | 128 |
| 13 | 140 | |
| 14 | 49 | |
| 15 | 53 | |
| 16 | 30 |
About M.G. Scordo
M.G. Scordo is a scholar working on Pharmacology, Biological Psychiatry and Psychiatry and Mental health, having authored 16 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (10 papers), Schizophrenia research and treatment (6 papers) and Diet and metabolism studies (4 papers). The work is most often cited by research in Pharmacology (733 citations), Psychiatry and Mental health (319 citations) and Biochemistry (128 citations). M.G. Scordo has collaborated with scholars based in Sweden, Italy and United States. Frequent co-authors include Edoardo Spina, Angela Avenoso, Aldo Madia, M. Ancione, Emilio Perucca, Marja‐Liisa Dahl, Mats Hidestrand, Norio Yasui‐Furukori, Gunnel Tybring and Arzu Gunes. Their work appears in journals such as Psychopharmacology, Clinical Pharmacology & Therapeutics and The Journal of Clinical Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.